Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose is to determine the effect of SLx-2101 dosed at 5mg or 10mg for 14 days on
systolic, diastolic pressures and heart rate in patients with hypertension.